Content you can trust

Editorial policy

Rules for analytical materials about medical AI agents, oncology pathways and clinical trials.

01

Primary sources

Priority goes to regulators, registries, international guidance, original studies and official product documentation.

02

Claim boundary

We distinguish deployment facts from vendor claims, technical metrics from clinical benefit and registry presence from access or patient outcomes.

03

Date and version

Every article is dated. Fast-changing product, study and regulatory information must be rechecked before practical use.

04

No treatment from an article

Materials do not provide a personal diagnosis, prescription, prognosis or recommendation to choose a provider, trial or paid service.

05

Corrections

Reports of factual errors are accepted by email; material corrections update the date and explain the reason.

06

Conflicts of interest

Commercial relationships, sponsorship or author participation must be disclosed. Payment must not determine the conclusion.

Found an error or outdated source?

Tell us which passage should be checked and link to a primary source. Do not send medical documents or health data.

Report an error
Back to publications